IT1252708B - Sali stabili dell'acido (+)-(1r,2s)-2((n-(2-idrossilammino-2-ossoetil)-n-metilammino)carbonil)cicloesan-1-carbossilico,ad attivita' ace inibitrice, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. - Google Patents

Sali stabili dell'acido (+)-(1r,2s)-2((n-(2-idrossilammino-2-ossoetil)-n-metilammino)carbonil)cicloesan-1-carbossilico,ad attivita' ace inibitrice, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.

Info

Publication number
IT1252708B
IT1252708B ITMI913448A ITMI913448A IT1252708B IT 1252708 B IT1252708 B IT 1252708B IT MI913448 A ITMI913448 A IT MI913448A IT MI913448 A ITMI913448 A IT MI913448A IT 1252708 B IT1252708 B IT 1252708B
Authority
IT
Italy
Prior art keywords
cyclohexan
ace
carbonyl
preparation
ossoethl
Prior art date
Application number
ITMI913448A
Other languages
English (en)
Italian (it)
Inventor
Raffaello Giorgi
Alessandro Subissi
Luigi Turbanti
Original Assignee
Guidotti & C Spa Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guidotti & C Spa Labor filed Critical Guidotti & C Spa Labor
Publication of ITMI913448A0 publication Critical patent/ITMI913448A0/it
Priority to ITMI913448A priority Critical patent/IT1252708B/it
Priority to AU30871/92A priority patent/AU657591B2/en
Priority to BR9205652A priority patent/BR9205652A/pt
Priority to PCT/EP1992/002903 priority patent/WO1993013056A1/en
Priority to EP92924726A priority patent/EP0575572A1/en
Priority to CA002104372A priority patent/CA2104372A1/en
Priority to HU9302389A priority patent/HUT69287A/hu
Priority to RU9293052414A priority patent/RU2079489C1/ru
Priority to JP5511398A priority patent/JPH06506002A/ja
Priority to CS923796A priority patent/CZ379692A3/cs
Priority to NZ245547A priority patent/NZ245547A/en
Priority to SK3796-92A priority patent/SK379692A3/sk
Priority to HR921454A priority patent/HRP921454A2/hr
Priority to MA23040A priority patent/MA22749A1/fr
Priority to SI9200409A priority patent/SI9200409A/sl
Priority to CN92113839A priority patent/CN1079474A/zh
Priority to YU110892A priority patent/YU110892A/sh
Priority to TNTNSN92117A priority patent/TNSN92117A1/fr
Priority to LVP-92-358A priority patent/LV10426B/lv
Priority to PL92297118A priority patent/PL169086B1/pl
Priority to ZA9210004A priority patent/ZA9210004B/xx
Priority to PT101156A priority patent/PT101156A/pt
Priority to MX9207543A priority patent/MX9207543A/es
Publication of ITMI913448A1 publication Critical patent/ITMI913448A1/it
Priority to BG98050A priority patent/BG98050A/bg
Priority to FI933685A priority patent/FI933685A/fi
Priority to NO93932982A priority patent/NO932982L/no
Priority to EE9400006A priority patent/EE9400006A/xx
Application granted granted Critical
Publication of IT1252708B publication Critical patent/IT1252708B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
ITMI913448A 1991-12-23 1991-12-23 Sali stabili dell'acido (+)-(1r,2s)-2((n-(2-idrossilammino-2-ossoetil)-n-metilammino)carbonil)cicloesan-1-carbossilico,ad attivita' ace inibitrice, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. IT1252708B (it)

Priority Applications (27)

Application Number Priority Date Filing Date Title
ITMI913448A IT1252708B (it) 1991-12-23 1991-12-23 Sali stabili dell'acido (+)-(1r,2s)-2((n-(2-idrossilammino-2-ossoetil)-n-metilammino)carbonil)cicloesan-1-carbossilico,ad attivita' ace inibitrice, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
AU30871/92A AU657591B2 (en) 1991-12-23 1992-12-12 Stable salts of (+)-(1S,2R)-2-((N-(2-hydroxylamino-2-oxoethyl)-N-methyl- amino)carbonyl)cyclohexane-1-carboxylic acid, process for their preparation and pharmaceutical compositions containing them
BR9205652A BR9205652A (pt) 1991-12-23 1992-12-12 Sais estáveis de (+) - (15,2R)-N- (2-hidroxilamina-2-oxoetil)N-metilamino carbonil ciclohexano-ácido carboxilico, processo de sua preparaçao, e composiçao farmaceutica
PCT/EP1992/002903 WO1993013056A1 (en) 1991-12-23 1992-12-12 Stable salts of (+)-(1s,2r)-2-[[n-(2-hydroxylamino-2-oxoethyl)-n-methyl-amino]carbonyl]cyclohexane-1-carboxylic acid, process for their preparation and pharmaceutical compositions containing them
EP92924726A EP0575572A1 (en) 1991-12-23 1992-12-12 Stable salts of (+)-(1s,2r)-2- n-(2-hydroxylamino-2-oxoethyl)-n-methyl-amino]carbonyl]cyclohexane-1-carboxylic acid, process for their preparation and pharmaceutical compositions containing them
CA002104372A CA2104372A1 (en) 1991-12-23 1992-12-12 Stable salts of (+)-(1s,2r)-2-¬¬n-(2-hydroxylamino-2-oxoethyl) -n-methyl-amino|carbonyl|cyclohexane-1-carboxylic acid, pro ess for their preparation and pharmaceutical compositions containing them
HU9302389A HUT69287A (en) 1991-12-23 1992-12-12 Process to prepare stable salts of(+)-(1s,2r)-2-{[n-(2-hydroxylamino-2-oxoethyl)-n-methyl-amino]carbonyl} cyclohexane-1-carboxylic acid and pharmaceutical compns. contg. them
RU9293052414A RU2079489C1 (ru) 1991-12-23 1992-12-12 Стабильные соли (+)-(1s,2r)-2[[n-(2-гидроксиамино-2-оксоэтил)-n-метиламино]-карбонил]циклогексан-1-карбоновой кислоты, способ их получения и фармацевтическая композиция
JP5511398A JPH06506002A (ja) 1991-12-23 1992-12-12 （＋）−（１ｓ，２ｒ）−２−［［ｎ−（２−ヒドロキシルアミノ−２−オキソエチル）−ｎ−メチル−アミノ］カルボニル］シクロヘキサン−１−カルボン酸の安定な塩
CS923796A CZ379692A3 (en) 1991-12-23 1992-12-21 Stable salts of (+)-(1s,2r)-2-//n-(2-hydroxylamino-2-oxoethyl)-n-methyl-amino/carbonyl /cyclohexane-1-carboxylic acid, process of their preparation and pharmaceutical compositions in which said stable salts are contained
NZ245547A NZ245547A (en) 1991-12-23 1992-12-21 Salts of (+)-(1s,2r)-2-[[n-(2-hydroxylamino-2- oxoethyl)-n-methylamino]carbonyl]cyclohexane-1- carboxylic acid with metals and organic bases; pharmaceutical compositions
SK3796-92A SK379692A3 (en) 1991-12-23 1992-12-21 Stable salts of (+)-(1s,2r)-2-//n-(2-hydroxylamino-2- -oxoethyl)-n-methyl-amino/carbonyl/cyclohexan-1-carboxylic acid, method of their preparation and pharmaceutical agents containing these salts
SI9200409A SI9200409A (en) 1991-12-23 1992-12-22 (+)-(1s,1r)-2-((n-(2-hydroxylamino-2-oxoethyl)-n-methyl-amino) carbonyl)cyclohexan-1-carboxylic acids stable salts, process for the preparation thereof and pharmaceutical preparations comprising the same
MA23040A MA22749A1 (fr) 1991-12-23 1992-12-22 Sels stables d'acide de (+)-(15,2r)-2-(n-2 hydroxylamino -2-oxoethyl) -n-methyl-amino) carbonyl) cyclo hexane -1-carboxylique; procede pour leur preparation et compositions pharmaceutiques les contenant
HR921454A HRP921454A2 (en) 1991-12-23 1992-12-22 Stable salts of (1r,2s)-2-n-(2-hydroxylamino-2-oxoethyl)-n-methyl-amino onyl cyclohexane-1-carboxylic acid, process for their aration and pharmaceutical compositions containing them
PT101156A PT101156A (pt) 1991-12-23 1992-12-23 Sais estaveis do acido (+)-(i,s,2r)-2-{{n-(2-hidroxilamino-2-oxoetil)n-metilamino}carboni}ciclo-hexano-1-carboxilico, seu processo de preparacao, composicoes farmaceuticas e uso como anti-hipertensivo
MX9207543A MX9207543A (es) 1991-12-23 1992-12-23 Sales estables de acido (+)-(1s,2r)-[[b.(2-hidroxilamino-2-oxoetil)-n-metilamino]carbonil]cicl ohexan-1-carboxilico, procedimiento para su preparacion, y composiciones farmaceuticas que las contienen
TNTNSN92117A TNSN92117A1 (fr) 1991-12-23 1992-12-23 Sels stables d'acide (+) (-1s,2r) -2 [n-2-hydroxylamino-2- oxoethyl] -n-methyl-amino] carbonyl] cyclohexane -1- carboxylique, procede pour leur preparation et compositions pharmaceutiques les contenant
LVP-92-358A LV10426B (en) 1991-12-23 1992-12-23 STABLE SALTS OF (+)-(1S,2R)-2-{£N-(2-hydroxylamino-2-oxoethyl)-N-methylamino|carbonyl}-cyclohexane-1-carbocyclic acid, process for their preparation and pharmaceutical compositions containing them
PL92297118A PL169086B1 (pl) 1991-12-23 1992-12-23 Sposób wytwarzania nowych soli kwasu (+)-(1 S,2R)-2-{[N-(2-hydroksyamino-2-ketoetylo)- N-metyloamino] karbonylo} cykloheksanokarboksylowego-1 PL
ZA9210004A ZA9210004B (en) 1991-12-23 1992-12-23 Stable salts of (+)-(1S,2R)-2-((N-(-2-hydroxylamino-2-oxoethyl)-N-methyl-amino)carbonyl)cyclohexane-1-carboxylic acid, process for their preparation and pharmaceutical compositions containing them
CN92113839A CN1079474A (zh) 1991-12-23 1992-12-23 新的抗高血压化合物及它们的制备方法和含它们的药物组合物
YU110892A YU110892A (sh) 1991-12-23 1992-12-23 Stabilne soli(+)-(1s,2r)-2-{[n-(2-hidroksiamino-2-oksoetil)-n-metilamino]karbonil}-cikloheksan-1-karbonske kiseline, postupak za njihovo dobijanje i preparati koji ih sadrže
BG98050A BG98050A (bg) 1991-12-23 1993-08-18 Устойчиви соли на (+)-(1s,2r)-2-//n-(2-хидроксиламино-2- оксоетил)-n-метил-амино/карбонил/циклохексан-1-карбонова киселина, метод за получаването им и фармацевтични състави, в които те се съдържат
FI933685A FI933685A (fi) 1991-12-23 1993-08-20 Stabila salter av (+)-(1s,2r)-2-((n-(2-hydroxylamino-2-oxoetyl)-n-metylamino)karbonyl)cyklohexan-1-karboxylsyra, deras framstaellningsmetoderoch farmaceutiska sammansaettningar innehaollande dessa
NO93932982A NO932982L (no) 1991-12-23 1993-08-20 Stabile salter av (+)-(1s,2r)-2-((n-(2-hydroksylamino-2-oksoetyl)-n-metylamino)karbonyl)cykloheksan-1-karboksylsyreog fremgangsmaate for fremstilling derav og farmasoeytiske sammensetninger som inneholder disse
EE9400006A EE9400006A (et) 1991-12-23 1994-05-23 (+)-(1R,2S)-2-[[N-(2-hüdroksüamino-2-oksoetüül)-N-metüülamino]karbonüül]tsükloh eksaan-1-karboksüülhappe stabiilsed soolad, nende valmistamise meetod ja neid sisaldavad farmakoloogilised ühendid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI913448A IT1252708B (it) 1991-12-23 1991-12-23 Sali stabili dell'acido (+)-(1r,2s)-2((n-(2-idrossilammino-2-ossoetil)-n-metilammino)carbonil)cicloesan-1-carbossilico,ad attivita' ace inibitrice, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.

Publications (3)

Publication Number Publication Date
ITMI913448A0 ITMI913448A0 (it) 1991-12-23
ITMI913448A1 ITMI913448A1 (it) 1993-06-23
IT1252708B true IT1252708B (it) 1995-06-26

Family

ID=11361409

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI913448A IT1252708B (it) 1991-12-23 1991-12-23 Sali stabili dell'acido (+)-(1r,2s)-2((n-(2-idrossilammino-2-ossoetil)-n-metilammino)carbonil)cicloesan-1-carbossilico,ad attivita' ace inibitrice, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.

Country Status (26)

Country Link
EP (1) EP0575572A1 (lv)
JP (1) JPH06506002A (lv)
CN (1) CN1079474A (lv)
AU (1) AU657591B2 (lv)
BG (1) BG98050A (lv)
BR (1) BR9205652A (lv)
CA (1) CA2104372A1 (lv)
CZ (1) CZ379692A3 (lv)
EE (1) EE9400006A (lv)
FI (1) FI933685A (lv)
HR (1) HRP921454A2 (lv)
HU (1) HUT69287A (lv)
IT (1) IT1252708B (lv)
LV (1) LV10426B (lv)
MA (1) MA22749A1 (lv)
MX (1) MX9207543A (lv)
NZ (1) NZ245547A (lv)
PL (1) PL169086B1 (lv)
PT (1) PT101156A (lv)
RU (1) RU2079489C1 (lv)
SI (1) SI9200409A (lv)
SK (1) SK379692A3 (lv)
TN (1) TNSN92117A1 (lv)
WO (1) WO1993013056A1 (lv)
YU (1) YU110892A (lv)
ZA (1) ZA9210004B (lv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264860B1 (it) * 1993-06-21 1996-10-17 Guidotti & C Spa Labor Derivati di acidi cis- e trans-2(((2-(isdrossiammino)-2-ossoetil)- alchilammino)carbonil)cicloesancarbossilici
US5639746A (en) * 1994-12-29 1997-06-17 The Procter & Gamble Company Hydroxamic acid-containing inhibitors of matrix metalloproteases
FR2817241B1 (fr) 2000-11-30 2003-03-07 Cebal Tube aluminium avec embout secable
EP2079304A4 (en) * 2006-09-28 2010-01-06 Merck & Co Inc AMINBASE SALTS FROM SAHA AND POLYMORPHE DAVON
US20210332635A1 (en) * 2020-04-27 2021-10-28 Carter-Hoffmann LLC Door movement system for cabinet

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1224627B (it) * 1988-04-12 1990-10-04 Guidotti & C Spa Labor Ammidi di acidi ciclometilen_1,2_dicarbossilici adattivita' terapeutica, procedimenti per la loro preparazione e composizioni farmaceutiche che le contengono.

Also Published As

Publication number Publication date
HU9302389D0 (en) 1993-11-29
ITMI913448A0 (it) 1991-12-23
LV10426A (lv) 1995-02-20
PL297118A1 (en) 1993-09-06
NZ245547A (en) 1995-12-21
LV10426B (en) 1995-08-20
JPH06506002A (ja) 1994-07-07
TNSN92117A1 (fr) 1993-06-08
EE9400006A (et) 1995-12-15
WO1993013056A1 (en) 1993-07-08
BG98050A (bg) 1994-04-29
FI933685A0 (fi) 1993-08-20
SK379692A3 (en) 1995-04-12
FI933685A (fi) 1993-08-20
HUT69287A (en) 1995-09-28
BR9205652A (pt) 1994-05-03
ZA9210004B (en) 1993-12-13
CN1079474A (zh) 1993-12-15
EP0575572A1 (en) 1993-12-29
AU3087192A (en) 1993-07-28
SI9200409A (en) 1993-09-30
ITMI913448A1 (it) 1993-06-23
HRP921454A2 (en) 1995-02-28
MX9207543A (es) 1993-08-01
RU2079489C1 (ru) 1997-05-20
MA22749A1 (fr) 1993-07-01
PT101156A (pt) 1994-06-30
CA2104372A1 (en) 1993-06-24
CZ379692A3 (en) 1993-09-15
YU110892A (sh) 1996-01-08
PL169086B1 (pl) 1996-05-31
AU657591B2 (en) 1995-03-16

Similar Documents

Publication Publication Date Title
KR100829875B1 (ko) 항암제로서의 병용 의약 조성물
LU90155I2 (fr) Vistide - cidofovir 75 mg/ml
YU23599A (sh) Stabilizovani antihistaminski sirup
MY116915A (en) Substituted indazole analogs
AU5895496A (en) Phenyldihydrobenzofurans
IT1263089B (it) Composti pirrol-amidinici, processi di preparazione e composizioni farmaceutiche che li contengono.
ES8207533A1 (es) Un procedimiento para la preparacion de derivados de pirazo-lopiridacina
FI945452A0 (fi) Ibuprofeenia sisältävä poreileva lääkevalmiste sekä sen valmistusmenetelmä
AU2736088A (en) Pharmaceutical compositions comprising benzylidene- and cinnamylidene-malononitrile derivatives for the inhibition of proliferative processes in mammalian cells, certain such novel compounds and their preparation
ES8600300A1 (es) Procedimiento para preparar nuevos derivados de 1, 3-dihidro-6-metilfuro-(3, 4-c)-piridina
US20210353627A1 (en) Novel quinazoline egfr inhibitors
AP2004003160A0 (en) Tolterodine salts
TNSN05247A1 (en) Use of carbamazepine derivatives for the treatment of agitation in dementia patients
IT1252708B (it) Sali stabili dell'acido (+)-(1r,2s)-2((n-(2-idrossilammino-2-ossoetil)-n-metilammino)carbonil)cicloesan-1-carbossilico,ad attivita' ace inibitrice, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT1262921B (it) Agenti antitumorali analoghi di oligopeptidi pirrol-amidinici retroversi processi di preparazione e prodotti farmaceutici che li contengono
ATE226214T1 (de) D-2-alkyltryptophan-enthaltende oligopeptidverbindungen, die die freisetzung von wachstumshormon fördern
ES8609324A1 (es) Un procedimiento para la preparacion de nuevas 1,3-dimetil-1h-purin-2,6-dionas
ZA200106214B (en) Pyrimidine-2,4,6-Triones as inhibitors of matrix metallo-proteinases.
US7488756B2 (en) Use of non-competitive and selective GluR5 antagonists as glutamate receptor modulating compounds
HU9301846D0 (en) Method for producing biphenylyl-quinuclidine compounds and medical preparatives containing them as active agent
RU93052414A (ru) Стабильные соли (+)-(1s, 2r)-2-[[n-(2-гидроксиамино-2-оксоэтил)-n-метиламино]карбонил]-циклогексан-1-карбоновой кислоты, способ их получения и фармацевтические композиции, содержащие их
GB1136104A (en) 2--‡-piperidyl-1,3:dioxane derivatives
GB1535778A (en) Compounds useful in treatment of unipolar depression
ITMI931418A1 (it) Enantiomeri farmacologicamente attivi
IT1130997B (it) Esteri e derivati chinucleidinici di acidi fenossicarbossilici,procedimento per la loro preparazione e relative composizioni farmaceutiche

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19961227